Advanced search
Publication Cover
Gynecological Endocrinology Volume 27, 2011 - Issue 11
Submit an article Journal homepage
282
Views
10
CrossRef citations to date
0
Altmetric
Art

Does supplementation with recombinant luteinizing hormone prevent ovarian hyperstimulation syndrome in down regulated patients undergoing recombinant follicle stimulating hormone multiple follicular stimulation for IVF/ET and reduces cancellation rate for high risk of hyperstimulation?

Donatella CasertaDepartment of Woman Health and Territory's Medicine, University of Rome Sapienza, S. Andrea Hospital, Rome, ItalyCorrespondence[email protected]
,
Franco LisiBiogenesi Villa Europa Clinic and Sterility and Fertility Unit, Villa Mafalda Clinic, Rome, Italy
,
Roberto Marci
,
Francesca CiardoDepartment of Woman Health and Territory's Medicine, University of Rome Sapienza, S. Andrea Hospital, Rome, Italy
,
Alessandra FaziDepartment of Woman Health and Territory's Medicine, University of Rome Sapienza, S. Andrea Hospital, Rome, Italy
,
Roberta LisiBiogenesi Villa Europa Clinic and Sterility and Fertility Unit, Villa Mafalda Clinic, Rome, Italy
&
Massimo MoscariniDepartment of Woman Health and Territory's Medicine, University of Rome Sapienza, S. Andrea Hospital, Rome, Italy
 show all
Pages 862-866 | Accepted 31 Mar 2011, Published online: 10 Mar 2011

Citations (10)

Keep up to date with the latest research on this topic with citation updates for this article.

Subscribe to citation updates

Read on this site (1)

Ilaria Soave & Roberto Marci. (2018) Exogenous luteinizing hormone supplementation in controlled ovarian stimulation: why, when and to whom?. Current Medical Research and Opinion 34:5, pages 939-941.
Read now

Articles from other publishers (9)

Meng Wang, Rui Huang, Xiaoyan Liang, Yundong Mao, Wenhao Shi & Qian Li. (2022) Recombinant LH supplementation improves cumulative live birth rates in the GnRH antagonist protocol: a multicenter retrospective study using a propensity score-matching analysis. Reproductive Biology and Endocrinology 20:1.
Crossref
Maryam Eftekhar & Nasim Tabibnejad. (2021) Recombinant luteinizing hormone supplementation in assisted reproductive technology: a review of literature. Middle East Fertility Society Journal 26:1.
Crossref
Amanda Souza Setti, Daniela Paes de Almeida Ferreira Braga, Assumpto IaconelliJúniorJúnior & Edson BorgesJúniorJúnior. (2021) Improving Implantation Rate in 2nd ICSI Cycle through Ovarian Stimulation with FSH and LH in GNRH Antagonist Regimen. Revista Brasileira de Ginecologia e Obstetrícia / RBGO Gynecology and Obstetrics 43:10, pages 749-758.
Crossref
Erica Velthuis, Julie Hubbard, Salvatore Longobardi & Thomas D’Hooghe. (2020) The Frequency of Ovarian Hyperstimulation Syndrome and Thromboembolism with Originator Recombinant Human Follitropin Alfa (GONAL-f) for Medically Assisted Reproduction: A Systematic Review. Advances in Therapy 37:12, pages 4831-4847.
Crossref
Carlo Alviggi, Alessandro Conforti, Sandro C. Esteves, Claus Yding Andersen, Ernesto Bosch, Klaus Bühler, Anna Pia Ferraretti, Giuseppe De Placido, Antonio Mollo, Robert Fischer & Peter Humaidan. (2018) Recombinant luteinizing hormone supplementation in assisted reproductive technology: a systematic review. Fertility and Sterility 109:4, pages 644-664.
Crossref
Monique H Mochtar, Nora A Danhof, Reuben Olugbenga Ayeleke, Fulco Van der Veen & Madelon van Wely. (2017) Recombinant luteinizing hormone (rLH) and recombinant follicle stimulating hormone (rFSH) for ovarian stimulation in IVF/ICSI cycles. Cochrane Database of Systematic Reviews 2017:5.
Crossref
Philippe Lehert, Efstratios M Kolibianakis, Christos A Venetis, Joan Schertz, Helen Saunders, Pablo Arriagada, Samuel Copt & Basil Tarlatzis. (2014) Recombinant human follicle-stimulating hormone (r-hFSH) plus recombinant luteinizing hormone versus r-hFSH alone for ovarian stimulation during assisted reproductive technology: systematic review and meta-analysis. Reproductive Biology and Endocrinology 12:1, pages 17.
Crossref
Ana Marcia M Cota, Joao Batista A Oliveira, Claudia G Petersen, Ana L Mauri, Fabiana C Massaro, Liliane FI Silva, Andreia Nicoletti, Mario Cavagna, Ricardo LR Baruffi & José G FrancoJrJr. (2012) GnRH agonist versus GnRH antagonist in assisted reproduction cycles: oocyte morphology. Reproductive Biology and Endocrinology 10:1.
Crossref
Heloisa L. Lavorato, Joao Batista A. Oliveira, Claudia G. Petersen, Laura Vagnini, Ana L. Mauri, Mario Cavagna, Ricardo L.R. Baruffi & Jose G. FrancoJr.Jr.. (2012) GnRH agonist versus GnRH antagonist in IVF/ICSI cycles with recombinant LH supplementation: DNA fragmentation and apoptosis in granulosa cells. European Journal of Obstetrics & Gynecology and Reproductive Biology 165:1, pages 61-65.
Crossref

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Order Reprints Request Corporate Permissions

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

Request Academic Permissions

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.